2004 Annual Meeting | Intra-arterial Thrombolysis for Acute Ischemic Stroke
06:45 AM - 06:55 AM |
Introduction - Welcome
|
|
06:55 AM - 07:10 AM |
Thombolytic Therapy for Acute Ischemic Stroke: Current Evidence
Jose I. Suarez, MD, FAAN |
|
07:10 AM - 07:30 AM |
New Agents for Thrombolysis: The Third Generation Thrombolytics
Hamza I. Maqsood, MD |
|
07:30 AM - 07:50 AM |
Post-Procedure Management and Complications of Intra-arterial Thrombolysis
Camilo R. Gomez, MD, FAAN |
|
07:50 AM - 08:30 AM |
Discussion
|
Jose I. Suarez, MD, FAAN | Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic. |
No disclosure on file | |
Hamza I. Maqsood, MD | Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
Camilo R. Gomez, MD, FAAN | Dr. Gomez has nothing to disclose. |